These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8250029)

  • 1. The relationship between plasma and dialysate lipoproteins and apoproteins in patients treated by continuous ambulatory peritoneal dialysis.
    Henkin Y; Neeman Z; Zuili I; Chaimovitz C; Shany S
    Am J Kidney Dis; 1993 Dec; 22(6):829-34. PubMed ID: 8250029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis.
    Steele J; Billington T; Janus E; Moran J
    Atherosclerosis; 1989 Sep; 79(1):47-50. PubMed ID: 2803346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of lipid abnormalities in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Ong-Ajyooth L; Sirisalee K; Shayakul C; Vareesangthip K; Vasuvattakul S; Vanichakarn S; Nimmannit S; Chirawong P; Ong-Ajyooth S; Nilwarangkur S
    Transplant Proc; 1994 Aug; 26(4):2077-9. PubMed ID: 8066677
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of continuous ambulatory peritoneal dialysis on plasma lipoproteins.
    Breckenridge WC; Roncari DA; Khanna R; Oreopoulos DG
    Atherosclerosis; 1982 Dec; 45(3):249-58. PubMed ID: 6961923
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased lipoprotein-remnant formation in chronic renal failure.
    Nestel PJ; Fidge NH; Tan MH
    N Engl J Med; 1982 Aug; 307(6):329-33. PubMed ID: 7088097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels.
    Kagan A; Bar-Khayim Y; Schafer Z; Fainaru M
    Kidney Int; 1990 Mar; 37(3):980-90. PubMed ID: 2313985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
    Kagan A; Elimalech E; Lemer Z; Fink A; Bar-Khayim Y
    Perit Dial Int; 1997; 17(3):243-9. PubMed ID: 9237284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased activity of plasma cholesteryl ester transfer protein in children with end-stage renal disease receiving continuous ambulatory peritoneal dialysis.
    Asayama K; Hayashibe H; Mishiku Y; Honda M; Ito H; Nakazawa S
    Nephron; 1996; 72(2):231-6. PubMed ID: 8684532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.
    Dieplinger H; Schoenfeld PY; Fielding CJ
    J Clin Invest; 1986 Apr; 77(4):1071-83. PubMed ID: 3082933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids, lipoproteins and apolipoproteins abnormalities in patients undergoing dialysis.
    Yang X; Wang H; Zhu Z; Deng A
    J Tongji Med Univ; 1997; 17(2):126-8. PubMed ID: 9639806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of lipid and lipoprotein profiles in long-term chronic ambulatory peritoneal dialysis (CAPD) in elderly patients with chronic renal failure (CRF).
    Kimak E; Berger B; Solski J; Janicka L; Ksiazek A
    Int Urol Nephrol; 2002; 33(1):203-4. PubMed ID: 12090332
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipoproteins in children treated with continuous peritoneal dialysis.
    Querfeld U; LeBoeuf RC; Salusky IB; Nelson P; Laidlaw S; Fine RN
    Pediatr Res; 1991 Feb; 29(2):155-9. PubMed ID: 2014151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein and apolipoprotein losses during continuous ambulatory peritoneal dialysis.
    Saku K; Sasaki J; Naito S; Arakawa K
    Nephron; 1989; 51(2):220-4. PubMed ID: 2915760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The uremic dyslipidemia: a cross-sectional and longitudinal study.
    Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
    Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
    Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis.
    Anwar N; Bhatnagar D; Short CD; Mackness MI; Durrington PN; Prais H; Gokal R
    Nephrol Dial Transplant; 1993; 8(1):71-4. PubMed ID: 8381941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis.
    Sniderman A; Cianflone K; Kwiterovich PO; Hutchinson T; Barre P; Prichard S
    Atherosclerosis; 1987 Jun; 65(3):257-64. PubMed ID: 3619989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
    Zwolińska D; Szprynger K
    Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein and apoprotein levels in different types of dialysis.
    Cassader M; Ruiu G; Tagliaferro V; Triolo G; Pagano G
    Int J Artif Organs; 1989 Jul; 12(7):433-8. PubMed ID: 2767788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.